NM_022469.4:c.56C>G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_022469.4(GREM2):c.56C>G(p.Ala19Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022469.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GREM2 | NM_022469.4 | c.56C>G | p.Ala19Gly | missense_variant | Exon 2 of 2 | ENST00000318160.5 | NP_071914.3 | |
GREM2 | XM_047427832.1 | c.110C>G | p.Ala37Gly | missense_variant | Exon 3 of 3 | XP_047283788.1 | ||
GREM2 | XM_047427839.1 | c.110C>G | p.Ala37Gly | missense_variant | Exon 4 of 4 | XP_047283795.1 | ||
GREM2 | XM_011544249.3 | c.56C>G | p.Ala19Gly | missense_variant | Exon 3 of 3 | XP_011542551.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000206 AC: 5AN: 242946Hom.: 0 AF XY: 0.0000301 AC XY: 4AN XY: 132788
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460046Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 726260
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.56C>G (p.A19G) alteration is located in exon 2 (coding exon 1) of the GREM2 gene. This alteration results from a C to G substitution at nucleotide position 56, causing the alanine (A) at amino acid position 19 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at